Archives of gynecology and obstetrics
-
Arch. Gynecol. Obstet. · Oct 2012
Randomized Controlled Trial Comparative StudyPain management after cesarean: a randomized controlled trial of oxycodone versus intravenous piritramide.
Primary objective was to assess whether oral analgesia with oxycodone offers superior pain relief after cesareans than patient controlled analgesia (PCA). Secondary outcomes were additional pain medication, time to first mobilization, therapeutic side effects, postoperative restrictions, overall satisfaction and costs. ⋯ General satisfaction with both treatment regimes was high. The results support the potential use of oral pain regimes and emphasis the importance of a multimodal approach to treat post-cesarean pain. Oral oxycodone is a not expensive, convenient and comparable analgesic to PCA devices with opioids after cesarean. Trial registration at clinicaltrials.gov identifier: NCT 01115101.
-
Arch. Gynecol. Obstet. · Oct 2012
Randomized Controlled Trial Comparative StudyType of axial analgesia does not influence time to vaginal delivery in a Proportional Hazards Model.
To create a Proportional Hazards Model of prospective factors associated with time-to-vaginal-delivery (TTVD). ⋯ Parity, labor augmentation, induction of labor and fetal weight determine TTVD; axial analgesia-related factors do not contribute to the model.
-
Arch. Gynecol. Obstet. · Oct 2012
A novel approach to postoperative bladder care in women after radical hysterectomy.
Currently, controversy exists with regard to the duration of bladder drainage and choice of catheter used in women who undergo radical hysterectomy. In this manuscript, we propose a novel approach to improving postoperative bladder care in women who undergo radical hysterectomy. ⋯ Removal of urinary catheter on the second postoperative day following radical hysterectomy is feasible and not associated with increased morbidity. This approach may be particularly useful to complement the introduction of laparoscopic and robotic surgical approaches for surgical management of cervical cancer.